SCHEMBL2835641

SCHEMBL2835641

CCOC(=O)N1Cc2occc2C(O)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
POLB P06746 2/20 0.38
DPP4 P27487 1/20 0.37
MAPT P10636 3/20 0.37
ABL1 P00519 1/20 0.37
RIN1 Q13671 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GAA P10253 3/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
MDM2 Q00987 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
NPC1 O15118 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2838800 0.87 NPC1 (0.42) ALDH1A1POLBMAPTGAALMNA
SCHEMBL5365358 0.74 RXRA (0.45) ALDH1A1L3MBTL1
SCHEMBL2840999 0.72 KMT2A (0.43) ALDH1A1POLBMAPTABL1RIN1
SCHEMBL21767046 0.69 LMNA (0.43) ALDH1A1POLBMAPTABL1RIN1
SCHEMBL2835727 0.69 L3MBTL1 (0.42) ALDH1A1POLBMAPTABL1RIN1
SCHEMBL2994358 0.67 SMN1; SMN2 (0.42) ALDH1A1POLBMAPTABL1RIN1
SCHEMBL2994354 0.67 SMN1; SMN2 (0.42) ALDH1A1POLBMAPTABL1RIN1
SCHEMBL2994360 0.67 SMN1; SMN2 (0.42) ALDH1A1POLBMAPTABL1RIN1
SCHEMBL2835764 0.66 GAA (0.40) ALDH1A1MAPTGAALMNAMEN1
SCHEMBL13077758 0.64 ABHD6 (0.63) ALDH1A1POLBMAPTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed
US-4636510-A 4-phenyl-tetrahydro-furano-pyridines and anti-depressant pharmaceutical compositions containing same BOEHRINGER INGELHEIM KG (DE) 1987-01-13 US disclosed
EP-0123998-A2 4-Phenyl-tetrahydro-furano-pyridines, process for their preparation and pharmaceutical compositions BOEHRINGER INGELHEIM KG (DE) 1984-11-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 ALDH1A1 66/4885POLB 3087/4885DPP4 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.